Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 1006 AL 1020

[Basal ganglia calcification]

Auffray-Calvier E, Lintia-Gaultier A, Bourcier R, Aguilar Garcia J.

Rev Med Interne. 2020 Jun;41(6):404-412. doi: 10.1016/j.revmed.2020.02.016. Epub 2020 Mar 9.

Effects of air pollution on the nervous system and its possible role in neurodevelopmental and neurodegenerative disorders

Costa LG, Cole TB, Dao K, Chang YC, Coburn J, Garrick JM.

Pharmacol Ther. 2020 Jun;210:107523. doi: 10.1016/j.pharmthera.2020.107523. Epub 2020 Mar 9.

Neuroinflammation: An overview of neurodegenerative and metabolic diseases and of biotechnological studies

de Araújo Boleti AP, de Oliveira Flores TM, Moreno SE, Anjos LD, Mortari MR, Migliolo L.

Neurochem Int. 2020 Jun;136:104714. doi: 10.1016/j.neuint.2020.104714. Epub 2020 Mar 9.

Inflammation: major denominator of obesity, Type 2 diabetes and Alzheimer's disease-like pathology?

Kacířová M, Zmeškalová A, Kořínková L, Železná B, Kuneš J, Maletínská L.

Clin Sci (Lond). 2020 Mar 13;134(5):547-570. doi: 10.1042/CS20191313.

Nutrition, Health, and Disease: Role of Selected Marine and Vegetal Nutraceuticals

Corzo L, Fernández-Novoa L, Carrera I, Martínez O, Rodríguez S, Alejo R, Cacabelos R.

Nutrients. 2020 Mar 11;12(3):747. doi: 10.3390/nu12030747.

PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson's disease

Ge P, Dawson VL, Dawson TM.

Mol Neurodegener. 2020 Mar 13;15(1):20. doi: 10.1186/s13024-020-00367-7.

GCH-1 genetic variant may cause Parkinsonism by unmasking the subclinical nigral pathology

Shin JH, Lee WW, Lee JY, Kim HJ, Jeon B.

J Neurol. 2020 Jul;267(7):1952-1959. doi: 10.1007/s00415-020-09788-2. Epub 2020 Mar 13.

Initiation of pharmacological therapy in Parkinson's disease: when, why, and how

de Bie RMA, Clarke CE, Espay AJ, Fox SH, Lang AE.

Lancet Neurol. 2020 May;19(5):452-461. doi: 10.1016/S1474-4422(20)30036-3. Epub 2020 Mar 12.

Measurement Properties of a 2-Dimensional Movement Analysis System: A Systematic Review and Meta-analysis

Lu Z, Nazari G, MacDermid JC, Modarresi S, Killip S.

Arch Phys Med Rehabil. 2020 Sep;101(9):1603-1627. doi: 10.1016/j.apmr.2020.02.011. Epub 2020 Apr 21.

From apathy to addiction: Insights from neurology and psychiatry

Kirschner M, Rabinowitz A, Singer N, Dagher A.

Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jul 13;101:109926. doi: 10.1016/j.pnpbp.2020.109926. Epub 2020 Mar 14.

Non-polyphenolic natural inhibitors of amyloid aggregation

Ma L, Yang C, Zheng J, Chen Y, Xiao Y, Huang K.

Eur J Med Chem. 2020 Apr 15;192:112197. doi: 10.1016/j.ejmech.2020.112197. Epub 2020 Mar 5.

Parkinson's disease treatment: past, present, and future

Elsworth JD.

J Neural Transm (Vienna). 2020 May;127(5):785-791. doi: 10.1007/s00702-020-02167-1. Epub 2020 Mar 14.

Mastering nocturnal jigsaws in Parkinson's disease: a dusk-to-dawn review of night-time symptoms

Bhidayasiri R, Sringean J, Trenkwalder C.

J Neural Transm (Vienna). 2020 May;127(5):763-777. doi: 10.1007/s00702-020-02170-6. Epub 2020 Mar 14.

Transgenic models for investigating the nervous system: Currently available neurofluorescent reporters and potential neuronal markers

Yamakawa M, Santosa SM, Chawla N, Ivakhnitskaia E, Del Pino M, Giakas S, Nadel A, Bontu S, Tambe A, Guo K, Han KY, Cortina MS, Yu C, Rosenblatt MI, Chang JH, Azar DT.

Biochim Biophys Acta Gen Subj. 2020 Jul;1864(7):129595. doi: 10.1016/j.bbagen.2020.129595. Epub 2020 Mar 12.

Advances in modelling alpha-synuclein-induced Parkinson's diseases in rodents: Virus-based models versus inoculation of exogenous preformed toxic species

Carta AR, Boi L, Pisanu A, Palmas MF, Carboni E, De Simone A.

J Neurosci Methods. 2020 May 15;338:108685. doi: 10.1016/j.jneumeth.2020.108685. Epub 2020 Mar 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias